Steris plc stock trades near yearly high on solid recent figures

Published on 09/01/2026 at 17:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Steris plc stock is trading close to its 52-week high after recent solid revenue and earnings figures, with a market capitalization above USD 22 billion and a tight trading range at the end of August 2026.

Architektur-Rendering eines modernen Glas- und Stahl-Firmensitzes mit gepflegter Außenanlage — Steris plc IE00BFY8C754 illustriert als Architektur-Render ein modernes gläsernes Firmengebäude der Medizintechnikbranche, Illustration mit AI erstellt.

Steris plc stock (ISIN IE00BFY8C754) is trading close to its recent yearly high, with the New York Stock Exchange listing showing a closing price of 232.64 USD as of August 31, 2026 and a market capitalization around 22.69 billion USD, according to market data compiled by a US stock portal and CompaniesMarketCap as of late August 2026.

Stock holds tight range into September 2026

According to a recent corporate-news overview, Steris plc stock closed at 232.64 USD on August 31, 2026, with an intraday low of 229.85 USD and an intraday high of 233.06 USD on the same day.

This trading range of 3.21 USD between low and high represents a relatively narrow band of about 1.4 percent around the closing level, indicating contained intraday volatility at the end of August 2026 ahead of the new month.

Market capitalization and valuation levels

The same data overview shows a market capitalization of 22.69 billion USD for Steris plc as of August 31, 2026, which is confirmed by a separate market-cap overview citing around 22.79 billion USD as of August 30, 2026.

For investors, these figures underline that Steris plc is positioned firmly in the large-cap segment, with the valuation corresponding to a price-earnings ratio around 28.57 based on recent data reported in the corporate-news summary.

This price-earnings ratio in the high twenties signals that the market is pricing in continued earnings growth and robust cash flows in the current fiscal period, making the development of margins and organic growth key points to monitor.

Go deeper

More market data and financial details on Steris plc

Further figures, news and regulatory filings on Steris plc can be accessed via the issuer overview and investor relations pages.

All Steris plc articles on ad-hoc-news.de Investor Relations

Steris portfolio in infection prevention

Steris plc, an Irish-registered medical technology group headquartered operationally in the United States, focuses on infection prevention, sterilization and surgical support solutions across hospitals, ambulatory centers and pharmaceutical manufacturers.

A representative product segment is its sterilization systems and services for healthcare facilities, which include equipment and consumables used in operating rooms and central sterile departments to protect patients and staff.

Stock perspective at the end of August 2026

With Steris plc stock closing at 232.64 USD on August 31, 2026 on the New York Stock Exchange and trading within an intraday range from 229.85 USD to 233.06 USD, the share remains close to its yearly highs, backed by a market capitalization of about 22.69 billion USD and a valuation in the high twenties in terms of the price-earnings ratio.